Legato Capital Management LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legato Capital Management LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$814,192
+86.3%
9,089
+77.1%
0.12%
+100.0%
Q2 2023$436,938
+84.2%
5,132
+79.0%
0.06%
+37.2%
Q1 2023$237,244
-4.8%
2,867
-9.5%
0.04%
-10.4%
Q4 2022$249,242
-67.5%
3,169
-76.0%
0.05%
-56.8%
Q4 2017$768,000
+29.5%
13,2240.0%0.11%
+26.1%
Q3 2017$593,000
+13.6%
13,2240.0%0.09%
-60.5%
Q2 2017$522,000
+866.7%
13,224
+889.8%
0.22%
+243.1%
Q1 2017$54,000
-99.9%
1,3360.0%0.06%
-93.3%
Q4 2016$53,707,0001,3360.97%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders